| Date | Stock | Signal | Target | Start Price | Best Price (1Y) | Accuracy | Current Price |
|---|---|---|---|---|---|---|---|
| Apr 13, 2026 |
Spyre Therapeutics Inc.
SYRE
|
BUY |
$98.00
Est. +55%
|
$63.26 | $84.43 |
Pending
|
$80.79
+27.7%
|
| Mar 13, 2026 |
Oruka Therapeutics, Inc.
ORKA
|
BUY |
$73.00
Est. +92%
|
$38.01 | $91.00 |
Target Met
|
$69.89
+83.9%
|
| Jan 09, 2026 |
Ardelyx Inc
ARDX
|
BUY |
$17.00
Est. +143%
|
$7.00 | $8.40 |
Pending
|
$5.69
-18.8%
|
| Jan 08, 2026 |
Abivax - ADR
ABVX
|
BUY |
$150.00
Est. +19%
|
$126.48 | $135.00 |
Pending
|
$96.55
-23.7%
|
| Dec 18, 2025 |
Mereo Biopharma Group Plc - ADR
MREO
|
BUY |
$6.00
Est. +213%
|
$1.92 | $2.36 |
Pending
|
$0.30
-84.6%
|
| Dec 11, 2025 |
Rezolute Inc
RZLT
|
BUY |
$5.00
Est. +257%
|
$1.40 | $4.71 |
Pending
|
$4.33
+209.3%
|
| Nov 24, 2025 |
Cullinan Therapeutics Inc
CGEM
|
BUY |
$38.00
Est. +219%
|
$11.90 | $16.74 |
Pending
|
$13.61
+14.4%
|
| Nov 19, 2024 |
Aclaris Therapeutics Inc
ACRS
|
BUY |
$8.00
Est. +155%
|
$3.14 | $5.17 |
Miss
|
$4.36
+38.9%
|
| Oct 18, 2024 |
Aura Biosciences Inc
AURA
|
BUY |
$24.00
Est. +133%
|
$10.29 | $12.38 |
Miss
|
$6.45
-37.3%
|
| Sep 20, 2024 |
Rezolute Inc
RZLT
|
BUY |
$15.00
Est. +522%
|
$2.41 | $8.82 |
Miss
|
$4.33
+79.7%
|
| Sep 10, 2024 |
Viridian Therapeutics Inc
VRDN
|
BUY |
$56.00
Est. +548%
|
$8.64 | $27.20 |
Miss
|
$16.30
+88.7%
|
| Jun 11, 2024 |
Viridian Therapeutics Inc
VRDN
|
BUY |
$46.00
Est. +610%
|
$6.48 | $27.20 |
Miss
|
$16.30
+151.5%
|
| May 20, 2024 |
Abivax - ADR
ABVX
|
BUY |
$43.00
Est. +215%
|
$13.64 | $14.16 |
Miss
|
$96.55
+607.8%
|
| May 10, 2024 |
Spyre Therapeutics Inc.
SYRE
|
BUY |
$40.00
Est. +14%
|
$35.19 | $40.26 |
Bullseye Hit (±1%)
|
$80.79
+129.6%
|
| Apr 12, 2024 |
Theravance Biopharma Inc
TBPH
|
BUY |
$21.00
Est. +135%
|
$8.93 | $10.87 |
Miss
|
$16.32
+82.8%
|
| Dec 08, 2022 |
Prometheus Biosciences Inc
RXDX
|
BUY |
$181.00
Est. +54%
|
$117.21 | $199.96 |
Target Met
|
$199.92
+70.6%
|
| Dec 08, 2022 |
Prometheus Biosciences Inc
RXDX
|
BUY |
$104.84
Est. +9%
|
$95.80 | $199.96 |
Target Met
|
$199.92
+108.7%
|
| Jul 27, 2022 |
Keros Therapeutics Inc
KROS
|
BUY |
$80.00
Est. +152%
|
$31.79 | - | - |
$10.24
-67.8%
|